These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080 [TBL] [Abstract][Full Text] [Related]
27. Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. Torlontano M; Crocetti U; Augello G; D'Aloiso L; Bonfitto N; Varraso A; Dicembrino F; Modoni S; Frusciante V; Di Giorgio A; Bruno R; Filetti S; Trischitta V J Clin Endocrinol Metab; 2006 Jan; 91(1):60-3. PubMed ID: 16219716 [TBL] [Abstract][Full Text] [Related]
28. Serial post-surgical stimulated and unstimulated highly sensitive thyroglobulin measurements in low- and intermediate-risk papillary thyroid carcinoma patients not receiving radioactive iodine. Kashat L; Orlov S; Orlov D; Assi J; Salari F; Walfish PG Endocrine; 2016 Nov; 54(2):460-466. PubMed ID: 27189148 [TBL] [Abstract][Full Text] [Related]
29. Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary. Domínguez JM; Nilo F; Contreras T; Carmona R; Droppelmann N; González H; Iturrieta V; Tuttle RM J Ultrasound Med; 2017 Nov; 36(11):2299-2307. PubMed ID: 28543974 [TBL] [Abstract][Full Text] [Related]
30. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment. Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265 [TBL] [Abstract][Full Text] [Related]
31. Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. Torlontano M; Crocetti U; D'Aloiso L; Bonfitto N; Di Giorgio A; Modoni S; Valle G; Frusciante V; Bisceglia M; Filetti S; Schlumberger M; Trischitta V Eur J Endocrinol; 2003 Jan; 148(1):19-24. PubMed ID: 12534353 [TBL] [Abstract][Full Text] [Related]
32. Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan. Chao M Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):438-47. PubMed ID: 20561773 [TBL] [Abstract][Full Text] [Related]
33. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer. Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858 [TBL] [Abstract][Full Text] [Related]
34. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. Mazzaferri EL; Robbins RJ; Spencer CA; Braverman LE; Pacini F; Wartofsky L; Haugen BR; Sherman SI; Cooper DS; Braunstein GD; Lee S; Davies TF; Arafah BM; Ladenson PW; Pinchera A J Clin Endocrinol Metab; 2003 Apr; 88(4):1433-41. PubMed ID: 12679418 [TBL] [Abstract][Full Text] [Related]
35. Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients. Lamartina L; Montesano T; Trulli F; Attard M; Torlontano M; Bruno R; Meringolo D; Monzani F; Tumino S; Ronga G; Maranghi M; Biffoni M; Filetti S; Durante C Endocrine; 2016 Nov; 54(2):467-475. PubMed ID: 26668060 [TBL] [Abstract][Full Text] [Related]